CLINICAL AND PATHOLOGICAL CORRELATIONS IN CHARCOT-MARIE-TOOTH NEUROPATHY TYPE 1A WITH THE 17P11.2P12 DUPLICATION - A CROSS-SECTIONAL MORPHOMETRIC AND IMMUNOHISTOCHEMICAL STUDY IN 20 CASES
Gm. Fabrizi et al., CLINICAL AND PATHOLOGICAL CORRELATIONS IN CHARCOT-MARIE-TOOTH NEUROPATHY TYPE 1A WITH THE 17P11.2P12 DUPLICATION - A CROSS-SECTIONAL MORPHOMETRIC AND IMMUNOHISTOCHEMICAL STUDY IN 20 CASES, Muscle & nerve, 21(7), 1998, pp. 869-877
In a cross-sectional, clinical, and morphometric analysis we assessed
the correlation between the clinical and pathological evolution of dis
ease in 20 unrelated patients of various ages affected by Charcot-Mari
e-Tooth neuropathy type 1A (CMT1A) with the 17p11.2p12 (peripheral mye
lin protein 22, PMP22) duplication. The severity of neurologic deficit
s and slowing of motor conduction velocity at the median nerve did not
vary significantly with the patients' age. The amount of demyelinatio
n was significantly higher below 15 years than in older age groups; in
contrast, myelinated fiber and onion bulb densities were similar at a
ll ages. The results indicate that in duplicated CMT1A, the pathologic
al process develops early in life and progresses little during the cou
rse of the disease. Younger patients had lower g-ratio values, suggest
ing that the trigger of demyelination in early years could be a hyperm
yelination, resulting from PMP22 overexpression. Yet none of the 20 pa
tients examined had immunohistochemical evidence of altered PMP22 expr
ession. The early onset and development of the disorder make it diffic
ult to detect PMP22 overdosage in nerve biopsies. (C) 1998 John Wiley
& Sons, Inc.